SCHEMBL172218

SCHEMBL172218

CC[N+](C)(C)CS(=O)(=O)O

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14964807 0.85 PTGS1 (0.32)
Sulfuric Acid SCHEMBL27503628 0.79 BBOX1 (0.42) BBOX1
SCHEMBL13133621 0.79 DNM1 (0.37) BBOX1
Sulfuric Acid SCHEMBL7640845 0.77 BBOX1 (0.41) BBOX1
Sulfuric Acid SCHEMBL27863635 0.77 BBOX1 (0.41) BBOX1
SCHEMBL14769374 0.76 LMNA (0.38)
SCHEMBL12296693 0.74 BBOX1 (0.39) BBOX1
Sulfuric Acid SCHEMBL18008312 0.74 BBOX1 (0.50) BBOX1
SCHEMBL172284 0.74 TSHR (0.39)
SCHEMBL17058679 0.74 DNM1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160354194-A1 ARTIFICIAL BLOOD VESSEL TORAY INDUSTRIES, INC. (JP) 2016-12-08 US disclosed
US-9487750-B2 Methods and compositions for growth of cells and embryonic tissue on a synthetic polymer matrix THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-11-08 US disclosed
US-20140255861-A1 METHODS AND COMPOSITIONS FOR GROWTH OF CELLS AND EMBRYONIC TISSUE ON A SYNTHETIC POLYMER MATRIX THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-09-11 US disclosed
US-8304171-B2 Plate making method of lithographic printing plate precursor FUJIFILM CORPORATION (JP) 2012-11-06 US disclosed
EP-2082875-B1 Lithographic printing plate precursor and plate making method using the precursor FUJIFILM CORP (JP) 2012-03-07 EP disclosed
US-20110217783-A1 CLEAVABLE SURFACTANTS AND METHODS OF USE THEREOF VANDERBILT UNIVERSITY 2011-09-08 US disclosed
US-20100248142-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE MAKING METHOD THEREOF FUJIFILM CORPORATION (JP) 2010-09-30 US disclosed
US-20100075260-A1 PLATE MAKING METHOD OF LITHOGRAPHIC PRINTING PLATE PRECURSOR FUJIFILM CORPORATION (JP) 2010-03-25 US disclosed
US-20100055607-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE MAKING METHOD THEREOF FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed
US-20090233222-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR FUJIFILM CORPORATION (JP) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110217783-A1 CLEAVABLE SURFACTANTS AND METHODS OF USE THEREOF PHOSPHO1, SGMS1, SGMS2 BBOX1 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.